Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Company Overview

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Key Stats

• Today's Range: $40.31 to $41.79
• 50-Day Range: $34.19 to $40.81
• 52-Week Range: $19.17 to $41.79
• Volume: 445,228 shs
• Average Volume: 379,098 shs
• Market Capitalization: $2.02 billion
• P/E Ratio: 48.91
• Dividend Yield: N/A
• Price Target: $41.33
• Consensus Rating: Moderate Buy

Guardian Pharmacy Services Stock Analysis - MarketRank™

Guardian Pharmacy Services scored higher than 41% of companies evaluated by MarketBeat, and ranked 630th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Guardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Guardian Pharmacy Services is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Guardian Pharmacy Services has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 11.02%

Earnings Growth

Earnings for Guardian Pharmacy Services are expected to grow by 11.02% in the coming year, from $1.18 to $1.31 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Guardian Pharmacy Services is 48.91, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.51.

Price to Earnings Ratio vs. Sector

The P/E ratio of Guardian Pharmacy Services is 48.91, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.87.

Price to Earnings Growth Ratio

Guardian Pharmacy Services has a PEG Ratio of 2.66. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Guardian Pharmacy Services has a P/B Ratio of 11.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.29% of the float of Guardian Pharmacy Services has been sold short.

Short Interest Ratio / Days to Cover

Guardian Pharmacy Services has a short interest ratio ("days to cover") of 6.28.

Change versus previous month

Short interest in Guardian Pharmacy Services has recently increased by 2.62%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Guardian Pharmacy Services does not currently pay a dividend.

Dividend Growth

Guardian Pharmacy Services does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: N/A

News Sentiment

Guardian Pharmacy Services has a news sentiment score of 1.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Guardian Pharmacy Services this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for GRDN on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.

MarketBeat Follows

1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Guardian Pharmacy Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $288,679,700.00 in company stock.

Percentage Held by Insiders

32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Guardian Pharmacy Services has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/06/2026
• Today: 6/08/2026
• Next Earnings (Estimated): 8/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Retail
• Current Symbol: NYSE:GRDN
• Previous Symbol: NYSE:GRDN
• CIK: 1802255
• Web: guardianpharmacy.com
• Phone: (404) 810-0089
• Fax: N/A
• Employees: 3,600
• Year Founded: 2004

Price Target and Rating

• Average Price Target for Guardian Pharmacy Services: $41.33
• High Price Target: $44.00
• Low Price Target: $36.00
• Potential Upside/Downside: +1.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.83
• Trailing P/E Ratio: 48.91
• Forward P/E Ratio: 34.41
• P/E Growth: 2.66
• Net Income: $49.22 million
• Net Margins: 3.64%
• Pretax Margin: 5.40%
• Return on Equity: 30.72%
• Return on Assets: 15.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.46
• Quick Ratio: 1.17

Sales & Book Value

• Annual Sales: $1.45 billion
• Price / Sales: 1.40
• Cash Flow: $1.26 per share
• Price / Cash Flow: 32.14
• Book Value: $3.44 per share
• Price / Book: 11.80

Miscellaneous

• Outstanding Shares: 49,780,000
• Free Float: 33,373,000
• Market Cap: $2.02 billion
• Optionable: N/A
• Beta: 0.08